AbilityPharma Competitors and Similar CompaniesClear all

AbilityPharma's competitors and similar companies include PDS Biotechnology, 4SC, BioLineRx and ImmunoPhotonics.
AbilityPharma
AbilityPharma
AbilityPharma (also known as Ability Pharmaceuticals) is a biopharmaceutical company developing drugs targeting cancer.
PDS Biotechnology
PDS Biotechnology
PDS Biotechnology is a biopharmaceutical company focused on the development and commercialization of therapies based on the versamune platform.
4SC
4SC
4SC is a biopharmaceutical company developing small-molecule drugs for the treatment of cancer.
BioLineRx
BioLineRx
BioLineRx is a biopharmaceutical company focused on oncology.
ImmunoPhotonics
ImmunoPhotonics
Immunophotonics is a biotechnology company developing a proprietary carbohydrate polymer.
Founding Date
Founding Date
2009
Founding Date
2005
Founding Date
1997
Founding Date
2003
Founding Date
2008
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Barcelona, ES HQ
Cerdanyola Del Vallès, ES
Locations
Princeton, US HQ
Florham Park, US
Locations
Planegg, DE HQ
Locations
Modi'in-Maccabim-Re'ut, IL HQ
Locations
St. Louis, US HQ
Employees
Employees
23
Employees
317% increase
Employees
13
Employees
2414% decrease
Employees
18
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
74 m
Valuation ($)
38.5 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
€336k (FY, 2024)
Revenue (est.)
$1.2m (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€84k (FY, 2024)
Cost of goods
$230k (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
€261k (FY, 2024)
Gross profit
$950k (FY, 2025)
Gross profit
N/A
Net income
Net income
N/A
Net income
($34.5m) (FY, 2025)
Net income
(€8.3m) (FY, 2024)
Net income
($2m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 2m
Total funding raised
N/A
Total funding raised
$ 100.9m
Total funding raised
$ 3.1m
For sources of this data, please see the company profile

View Company Profiles

PDS Biotechnology
HQ
Princeton, US
Employees
31↑ 7% increase

PDS Biotechnology is a biopharmaceutical company focused on the development and commercialization of therapies based on the versamune platform.

View company
4SC
HQ
Planegg, DE
Employees
13

4SC is a biopharmaceutical company developing small-molecule drugs for the treatment of cancer.

View company
BioLineRx
HQ
Modi'in-Maccabim-Re'ut, IL
Employees
24↓ 14% decrease

BioLineRx is a biopharmaceutical company focused on oncology.

View company
ImmunoPhotonics
HQ
St. Louis, US
Employees
18

Immunophotonics is a biotechnology company developing a proprietary carbohydrate polymer.

View company